Pharmacogenomic Analysis in Pediatric Acute Lymphoblastic Leukemia
Completed
- Conditions
- Acute Lymphoblastic Leukemia, PediatricAdverse Drug Event
- First Posted Date
- 2021-02-25
- Last Posted Date
- 2023-02-16
- Lead Sponsor
- Cipherome, Inc.
- Target Recruit Count
- 80
- Registration Number
- NCT04770922
- Locations
- ๐บ๐ธ
Stanford University, Stanford, California, United States
Evaluating Pharmacogenomic Variants for Cardiology Therapeutics
Not Applicable
Completed
- Conditions
- BleedingIschemic StrokeMyocardial InfarctionThrombosisStent Thrombosis
- Interventions
- Diagnostic Test: Cipherome Lighthouse Pilot
- First Posted Date
- 2021-01-08
- Last Posted Date
- 2023-09-29
- Lead Sponsor
- Cipherome, Inc.
- Target Recruit Count
- 300
- Registration Number
- NCT04702113
- Locations
- ๐บ๐ธ
Doctors Hospital at Renaissance, Edinburg, Texas, United States
Association Between Genetic Variant Scores and DOACs (DARES2)
Completed
- Conditions
- Drug-Related Side Effects and Adverse ReactionsIatrogenic Disorder
- First Posted Date
- 2020-10-22
- Last Posted Date
- 2023-08-16
- Lead Sponsor
- Cipherome, Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT04597593
- Locations
- ๐ฐ๐ท
SNUBH, Seongnam-si, Gyonggi-do, Korea, Republic of
DOAC ADRs Retrospective Study on Genetic Variations
Completed
- Conditions
- Drug-Related Side Effects and Adverse ReactionsTreatment Failure
- First Posted Date
- 2020-10-08
- Last Posted Date
- 2023-02-16
- Lead Sponsor
- Cipherome, Inc.
- Target Recruit Count
- 210
- Registration Number
- NCT04580589
- Locations
- ๐บ๐ธ
Santa Clara Valley Medical Center, Santa Clara, California, United States
Association Between Genetic Variant Scores and P2Y12 Inhibitor Effects
Completed
- Conditions
- Ischemic StrokeMyocardial InfarctionStent ThrombosisAcute Coronary Syndrome
- First Posted Date
- 2020-10-08
- Last Posted Date
- 2023-02-16
- Lead Sponsor
- Cipherome, Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT04580602
- Locations
- ๐ฐ๐ท
SNUBH, Seongnam-si, Gyonggi-do, Korea, Republic of
DOAC ADRs Retrospective Study
Terminated
- Conditions
- Drug-Related Side Effects and Adverse Reactions
- First Posted Date
- 2020-01-30
- Last Posted Date
- 2021-03-08
- Lead Sponsor
- Cipherome, Inc.
- Target Recruit Count
- 3
- Registration Number
- NCT04247919
- Locations
- ๐บ๐ธ
Santa Clara Valley Medical Center, San Jose, California, United States
Association Between Genetic Variant Scores and Warfarin Effect
Completed
- Conditions
- Atrial FibrillationDeep Vein ThrombosisIntracardiac ThrombusPulmonary EmbolismVenous Thromboembolic Disease
- First Posted Date
- 2019-03-29
- Last Posted Date
- 2023-02-16
- Lead Sponsor
- Cipherome, Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT03894878
- Locations
- ๐บ๐ธ
Santa Clara Valley Medical Center, Santa Clara, California, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath